Annette Kopp-Schneider

From MaRDI portal
Revision as of 15:37, 27 February 2024 by AuthorDisambiguator (talk | contribs) (AuthorDisambiguator moved page Annette Kopp-Schneider to Annette Kopp-Schneider: Duplicate)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Person:208211

Available identifiers

zbMath Open kopp-schneider.annetteDBLP49/9916WikidataQ37610900 ScholiaQ37610900MaRDI QIDQ208211

List of research outcomes

PublicationDate of PublicationType
The design heatmap: A simple visualization of ‐optimality design problems2021-07-09Paper
Functional analysis of high-content high-throughput imaging data2020-12-04Paper
Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control2020-07-17Paper
Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions—A calibration approach2020-01-15Paper
Optimal experimental designs for estimating the drug combination index in toxicology2018-08-17Paper
Addressing small sample size bias in multiple‐biomarker trials: Inclusion of biomarker‐negative patients and Firth correction2018-04-11Paper
Prediction accuracy and variable selection for penalized cause‐specific hazards models2018-04-11Paper
Multiple‐rater kappas for binary data: Models and interpretation2018-04-11Paper
Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints2017-08-18Paper
Summarizing EC50 estimates from multiple dose‐response experiments: A comparison of a meta‐analysis strategy to a mixed‐effects model approach2014-06-11Paper
Application of a two-phenotype color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment2010-06-11Paper
https://portal.mardi4nfdi.de/entity/Q53865742008-05-14Paper
Application of a color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment2006-10-10Paper
Incorporating phenotype-dependent growth rates into the color-shift model for preneoplastic hepatocellular lesions2003-04-02Paper
Modeling cancer detection: Tumor size as a source of information on unobservable stages of carcinogenesis2002-10-09Paper
Using a stochastic model to analyze the sequence of phenotypic changes in rat liver focal lesions2002-01-02Paper
A model for hepatocarcinogenesis with clonal expansion of three successive phenotypes of preneoplastic cells2001-10-30Paper
Multistage, stochastic models of the cancer process: A general theory for calculating tumor incidence2001-07-15Paper
A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events2001-01-29Paper
Calculating tumor incidence rates in stochastic models of carcinogenesis1997-01-16Paper
A stem cell model for carcinogenesis1994-07-07Paper
Birth-death processes with piecewise constant rates1992-06-28Paper
The application of a multistage model that incorporates DNA damage and repair to the analysis of initiation/promotion experiments1991-01-01Paper

Research outcomes over time


Doctoral students

No records found.


Known relations from the MaRDI Knowledge Graph

PropertyValue
MaRDI profile typeMaRDI person profile
instance ofhuman


This page was built for person: Annette Kopp-Schneider